This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: At&t Intellectual Property I, LP. Active years: 2019-2022.
Company Filing History:
Years Active: 2019-2022
Title: Michael Osborne Isom: Innovator in Medication Adherence Monitoring
Introduction
Michael Osborne Isom is a notable inventor based in West Valley City, UT (US). He has made significant contributions to the field of medication adherence monitoring, holding a total of 3 patents. His work focuses on developing innovative solutions to improve patient compliance with medication regimens.
Latest Patents
One of Isom's latest patents involves a device designed for monitoring a patient's medication adherence. This apparatus includes a set of contact pins that electrically engage a conductive trace circuit of unit dose packaging. It generates a signal in response to a break in the conductive trace circuit. The device features a processor with multiple analog channels to detect and record the signal. Additionally, it includes a cellular modem that transmits information about the signal to a medication adherence monitoring service via a data network. The housing of the device is designed for the removable insertion of unit dose packaging and includes a lock to securely hold the packaging in place.
Career Highlights
Michael Osborne Isom is currently employed at AT&T Intellectual Property I, LP. His role at the company allows him to leverage his expertise in developing innovative technologies that enhance patient care and medication management.
Collaborations
Isom has collaborated with talented individuals such as Mohamed Ahmed Mohamed Elmahdy and Nadia Morris. These partnerships have contributed to the advancement of his projects and the successful development of his patents.
Conclusion
Michael Osborne Isom is a dedicated inventor whose work in medication adherence monitoring is making a positive impact on healthcare. His innovative solutions are paving the way for improved patient outcomes and adherence to medication regimens.
